trending Market Intelligence /marketintelligence/en/news-insights/trending/zXujBGk-0Dnn2_MCya9QmA2 content esgSubNav
In This List

Knight Therapeutics ups stake in Crescita

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Knight Therapeutics ups stake in Crescita

Knight Therapeutics Inc. upped its stake in Crescita Therapeutics Inc. by 4% to 14.9%.

The company acquired 566,471 new Crescita shares and continues to hold 396,000 warrants, which, if fully exercised, will increase its stake by an additional 2.3%.

The new shares were issued as part of an agreement dated Aug. 31, 2016.

Knight now owns a total of 2,079,973 Crescita shares, which are held for investment purposes.